EXTRACCIÓN DE COMPUESTOS FENÓLICOS DE LA CÁSCARA DE LIMA (Citrus limetta Risso) Y DETERMINACIÓN DE SU ACTIVIDAD ANTIOXIDANTE

Los desechos que se tienen de la obtención de jugos son principalmente cáscara y bagazo, sin embargo son una buena fuente de compuestos fenólicos, mayoritariamente de flavonoides. El objetivo de este trabajo fue extraer y cuantificar el contenido fenólico de la cáscara de lima, así como su actividad antioxidante. Esto se determinó evaluando el mejor sistema de extracción de compuestos fenólicos y flavonoides, teniendo como variables: tipo de solvente (metanol, acetona y hexano) y tamaño de partícula (tamiz 20 (T1) y 50 (T2)). La determinación de la actividad antioxidante se realizó mediante dos métodos ABTS•+ y DPPH•, comparando la efectividad entre ellos. El mejor modelo de extracción de los compuestos fenólicos y flavonoides fue utilizando metanol como solvente y un tamaño de partícula pequeño (300 μm). El valor más alto de actividad antioxidante (91,69 %) se obtuvo con el método ABTS•+, en los extractos con metanol y acetona, sin diferencias entre los tamices utilizados. La cáscara de lima tiene 8,79 mg EAG/g ms y 14,325 mg quercetina/g ms. La utilización de cáscara de lima representa una alternativa para el aprovechamiento de biocompuestos, que son considerados como sustitutos de los antioxidantes sintéticos existentes

Five insights from the Global Burden of Disease Study 2019

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3.5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers.Peer reviewe

Five insights from the Global Burden of Disease Study 2019

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3·5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers

Five insights from the Global Burden of Disease Study 2019

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3·5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers